Drug Approval | July 13, 2024
Lupin receives EIR from USFDA for its Dabhasa facility
The facility is a part of Lupin Manufacturing Solutions
The facility is a part of Lupin Manufacturing Solutions
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
KIMS already have a multi-specialty hospital and gastro unit at Vizag
The Unit has been issued GMP Certification from ANVISA-Brazil
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
Diroximel Fumarate Delayed-Release Capsules is indicated for the treatment of relapsing forms of multiple sclerosis
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
Subscribe To Our Newsletter & Stay Updated
